These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3677431)

  • 41. Red blood cell lithium-sodium countertransport in the tecumseh blood pressure study.
    Weder AB; Schork NJ; Krause L; Julius S
    Hypertension; 1991 May; 17(5):652-60. PubMed ID: 2022408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of the lithium ratio in man by means of an in vitro test.
    Rybakowski J; Frazer A; Mendels J; Ramsey TA
    Clin Pharmacol Ther; 1977 Oct; 22(4):465-9. PubMed ID: 902459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of Li(+)-Na+ countertransport by physiological levels of insulin in vitro.
    Foyle WJ; Drury PL
    J Hypertens; 1991 Aug; 9(8):713-7. PubMed ID: 1655881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assay of human erythrocyte sodium-dependent lithium efflux: the importance of timing of blood sampling.
    Adebayo GI; Gaffney P; Sinnott M; Feely J
    Eur J Clin Invest; 1996 Feb; 26(2):131-5. PubMed ID: 8904522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Red blood cell sodium-lithium countertransport in patients with essential and renal hypertension.
    Petrov VV; Arabidze CG; Levitsky DO; Eliseev AO; Lijnen PJ
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):153-7. PubMed ID: 8007744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alternative splicing of NHE-1 mediates Na-Li countertransport and associates with activity rate.
    Zerbini G; Maestroni A; Breviario D; Mangili R; Casari G
    Diabetes; 2003 Jun; 52(6):1511-8. PubMed ID: 12765964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of magnesium on passive fluxes of lithium in the human erythrocyte.
    Wiley JS; Bonacquisto L; Doyle AE
    Clin Exp Pharmacol Physiol; 1985; 12(3):311-4. PubMed ID: 4028517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetics of sodium-lithium countertransport activity in patients with uncomplicated type 1 diabetes.
    Rutherford PA; Thomas TH; Carr SJ; Taylor R; Wilkinson R
    Clin Sci (Lond); 1992 Mar; 82(3):291-9. PubMed ID: 1312414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulphydryl group control of sodium-lithium countertransport kinetics: a membrane protein control abnormality in essential hypertension.
    Thomas TH; Rutherford PA; West IC; Wilkinson R
    Eur J Clin Invest; 1995 Apr; 25(4):235-40. PubMed ID: 7601199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man.
    Petrov VV; Britov AN; Levitsky DO; Minchenko BI; Konstantinov EN; Svidersky VD; Novikov ID; Grishenkov EA; Lijnen PJ
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):661-6. PubMed ID: 7746028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythrocyte sodium-lithium countertransport is not different in type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Elving LD; Wetzels JF; de Nobel E; Berden JH
    Diabetologia; 1991 Feb; 34(2):126-8. PubMed ID: 2065847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythrocyte Na(+)-Li+ countertransport in essential hypertension: correlation with membrane lipids levels.
    Villar J; Montilla C; Muñiz-Grijalvo O; Muriana FG; Stiefel P; Ruiz-Gutiérrez V; Carneado J
    J Hypertens; 1996 Aug; 14(8):969-73. PubMed ID: 8884551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythrocyte sodium lithium countertransport in heart transplantation.
    Vareesangthip K; Thongtang V; Hanlakorn P; Pidetcha P; Suwannaton L; Ong-Aj-Yooth L
    Transplant Proc; 2001; 33(7-8):3561-3. PubMed ID: 11750515
    [No Abstract]   [Full Text] [Related]  

  • 54. Sodium-lithium countertransport in children with nephrotic syndrome.
    Tulassay T; Dobos M; Luczay A; Stubnya G; Reusz GS; Vásárhelyi B; Sallay P; Szabó A
    Pediatr Nephrol; 1999 Aug; 13(6):510-3. PubMed ID: 10452280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nisoldipine blocks the increase of intracellular free calcium-ion concentration associated with elevated sodium-lithium countertransport activity in erythrocytes in patients with NIDDM.
    Fujita J; Tsuda K; Obayashi H; Fukui I; Ishida H; Seino Y
    Diabet Med; 1997 Jun; 14(6):499-502. PubMed ID: 9212318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic differences in lithium-sodium exchange and regulation of the sodium-hydrogen exchanger in essential hypertension.
    Canessa ML; Morgan K; Semplicini A
    J Cardiovasc Pharmacol; 1988; 12 Suppl 3():S92-8. PubMed ID: 2467112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thiol group control of sodium-lithium countertransport kinetics in uraemia: evidence of a membrane abnormality affected by haemodialysis.
    Rutherford PA; Thomas TH; O'Kelly J; West IC; Wilkinson R
    Nephron; 1996; 72(2):184-8. PubMed ID: 8684524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraerythrocytic cation metabolism in children with uremia undergoing hemodialysis.
    DeSanto NG; Trevisan M; DeColle S; DiMuro M; DeChiara F; Latte M; Franzese A; Iacono R; Capasso G; Capodicasa G
    J Lab Clin Med; 1987 Aug; 110(2):231-6. PubMed ID: 3598350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversible alteration of red cell lithium-sodium countertransport in patients with thyroid disease.
    Brent GA; Canessa M; Dluhy RG
    J Clin Endocrinol Metab; 1989 Feb; 68(2):322-8. PubMed ID: 2918049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythrocyte Li-Na countertransport in uremic patients: effect of urea.
    Sun YF; Tsai CJ; Hsieh CC; Lau YT
    Chin J Physiol; 1996; 39(3):177-81. PubMed ID: 8955564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.